---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-011729"
form_type: "8-K"
ticker: "NVNO"
cik: "0001661053"
company_name: "enVVeno Medical Corp"
filed_at: "2025-05-20T23:59:59+00:00"
generated_at: "2026-05-21T00:09:18.260270+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# enVVeno Medical appoints Jennifer Bright as CFO, replacing Craig Glynn

## Summary
- Craig Glynn resigned as CFO effective May 19, 2025; will serve as consultant for transition.
- Jennifer Bright appointed CFO; 25+ yr CPA, ex-CFO of BIOLASE, salary $300K, bonus up to 40%.
- Bright awarded 350,000 stock options at $3.62/share, vesting over 3 years with 1-year cliff.
- No disagreement with Glynn; standard employment and indemnification agreements signed.

## SEC filing metadata
- accession: 0001641172-25-011729
- form_type: 8-K
- ticker: NVNO
- cik: 0001661053
- company_name: enVVeno Medical Corp
- filed_at: 2025-05-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661053/000164117225011729/0001641172-25-011729-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661053/000164117225011729/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-011729
- JSON: https://secwatch.observer/filing/0001641172-25-011729.json
- Plain text: https://secwatch.observer/filing/0001641172-25-011729.txt

## Key facts
- Executive change
  Jennifer Bright was appointed as Chief Financial Officer at enVVeno Medical Corp.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On May 19, 2025, the Board of Directors (the “ Board ”) of enVVeno Medical Corporation (the “ Company ”) appointed Jennifer Bright as Chief Financial Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661053/000164117225011729/0001641172-25-011729-index.htm
- Executive change
  Craig Glynn resigned as Chief Financial Officer at enVVeno Medical Corp.
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On May 19, 2025, Craig Glynn resigned as Chief Financial Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661053/000164117225011729/0001641172-25-011729-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.